封面
市場調查報告書
商品編碼
1620607

免疫保健補充劑市場機會、成長動力、行業趨勢分析和預測 2024 - 2032

Immune Health Supplements Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 145 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023 年,全球免疫健康補充劑市場估值為 253 億美元,預計 2024 年至 2032 年將以 9.8% 的年複合成長率(CAGR) 成長。礦物質、草藥和其他成分,旨在增強免疫功能,減少疾病的嚴重程度和持續時間,並促進整體健康。該市場成長的主要動力是慢性病盛行率的增加,導致對免疫保健補充劑的需求增加。隨著慢性病患者尋求增強免疫系統的方法,市場不斷擴大。此外,健康意識的增強,尤其是老齡化人口的健康意識的增強,進一步推動了這項需求。

老年人更容易出現免疫力下降的情況,因此擴大轉向補充劑作為預防性健康措施。補充劑配方的創新也有助於市場成長。這些進步可以提供更有針對性和更有效的免疫支持,將免疫保健補充劑定位為主動醫療保健策略的重要組成部分。就產品類型而言,市場分為維生素、礦物質補充劑、草藥補充劑、益生菌、氨基酸、omega-3 脂肪酸和電解質等類別。

維生素領域在 2023 年價值達 73 億美元,在市場中佔據主導地位,預計將繼續成長。眾所周知,必需維生素 A、C、D 和 E 在支持免疫功能方面發揮著至關重要的作用,因此備受追捧。從劑型來看,市場分為膠囊劑、錠劑、粉末劑、液體劑等。膠囊到 2023 年將佔據 34.2% 的市場佔有率,預計將大幅成長。

市場範圍
開始年份 2023年
預測年份 2024-2032
起始值 253億美元
預測值 580 億美元
複合年成長率 9.8%

它們提供更好的生物利用度,使營養物質更快被吸收到血液中。某些膠囊配方也設計用於延遲或定向釋放,確保活性成分在消化系統內的最佳點被吸收。從地區來看,北美預計將主導免疫保健品市場,預計到 2032 年該地區將達到 232 億美元。糖尿病、癌症和自體免疫疾病等慢性病的高發生率是推動該地區需求的重要因素。

監管監督確保這些產品符合安全和標籤標準,進一步增強消費者對現有補充劑的功效和品質的信心。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 慢性病盛行率上升
      • 提高健康意識
      • 老年人口不斷增加
      • 補充劑配方的創新
    • 產業陷阱與挑戰
      • 高級補充劑相關的高成本
      • 潛在的副作用
  • 成長潛力分析
  • 監管環境
  • 技術景觀
  • 未來市場趨勢
  • 波特的分析
  • PESTEL分析

第 4 章:競爭格局

  • 介紹
  • 公司市佔率分析
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章:市場估計與預測:按產品類型,2021 - 2032 年

  • 主要趨勢
  • 維生素
    • 維生素A
    • 複合維生素B
    • 維生素C
    • 維生素D
    • 維生素E
    • 維生素K
  • 礦物質補充劑
    • 鋅補充劑
    • 鐵補充劑
    • 鎂補充劑
    • 其他礦物質補充劑
  • 草藥補充劑
  • 益生菌補充劑
  • 胺基酸和蛋白質
  • Omega 3脂肪酸
  • 電解質補充劑

第 6 章:市場估計與預測:按配方分類,2021 - 2032 年

  • 主要趨勢
  • 膠囊
  • 平板電腦
  • 粉末
  • 液體
  • 其他配方

第 7 章:市場估計與預測:按來源類型,2021 - 2032 年

  • 主要趨勢
  • 自然的
  • 合成的

第 8 章:市場估計與預測:以用藥方式分類,2021 - 2032 年

  • 主要趨勢
  • 處方
  • 場外交易 (OTC)

第 9 章:市場估計與預測:按配銷通路,2021 - 2032 年

  • 主要趨勢
  • 線下零售店
    • 藥局和藥局
    • 大型超市/超市
    • 便利商店
  • 網路零售店

第 10 章:市場估計與預測:按地區,2021 - 2032

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章:公司簡介

  • Abbott Laboratories
  • American Health
  • Amway
  • Bayer
  • Cargill
  • Danone
  • Herbalife Nutrition of America
  • Himalaya Global Holdings
  • MegaFood
  • Metagenics
  • Nordic Naturals
  • NOW Foods
  • Nestle
  • Swisse Wellness
  • The Nature's Bounty
簡介目錄
Product Code: 11937

The Global Immune Health Supplements Market was valued at USD 25.3 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 9.8% from 2024 to 2032. These supplements, designed to support the immune system, include a range of vitamins, minerals, herbs, and other ingredients that aim to enhance immune function, reduce the severity and duration of illness, and promote overall health. A major driver behind this market's growth is the increasing prevalence of chronic diseases, leading to greater demand for immune health supplements. As individuals with chronic conditions seek ways to strengthen their immune systems, the market continues to expand. Additionally, growing health awareness, particularly among aging populations, further fuels this demand.

The elderly, being more prone to immune decline, are increasingly turning to supplements as a preventive health measure. Innovations in supplement formulations are also contributing to market growth. These advancements allow for more targeted and effective immune support, positioning immune health supplements as essential components of proactive healthcare strategies. In terms of product types, the market is segmented into categories like vitamins, mineral supplements, herbal supplements, probiotics, amino acids, omega-3 fatty acids, and electrolytes.

The vitamins segment, valued at USD 7.3 billion in 2023, dominated the market and is expected to continue growing. Essential vitamins like A, C, D, and E are known to play a crucial role in supporting immune function, making them highly sought-after. When looking at formulations, the market is categorized into capsules, tablets, powder, liquid, and others. Capsules, which held a 34.2% market share in 2023, are anticipated to see substantial growth.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$25.3 Billion
Forecast Value$58 Billion
CAGR9.8%

They offer better bioavailability, allowing nutrients to be absorbed more quickly into the bloodstream. Certain capsule formulations are also designed for delayed or targeted release, ensuring that the active ingredients are absorbed at optimal points within the digestive system. Regionally, North America is expected to dominate the immune health supplements market, with the region forecasted to reach USD 23.2 billion by 2032. The U.S. led the North American market in 2023, generating revenue of USD 9.4 billion. The high incidence of chronic diseases, such as diabetes, cancer, and autoimmune disorders, is a significant factor driving demand in the region.

Regulatory oversight ensures that these products meet safety and labeling standards, further boosting consumer confidence in the efficacy and quality of the supplements available.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of chronic diseases
      • 3.2.1.2 Increasing health awareness
      • 3.2.1.3 Rising geriatric population
      • 3.2.1.4 Innovations in supplement formulations
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High costs associated with advanced supplements
      • 3.2.2.2 Potential side effects
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Future market trends
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Vitamins
    • 5.2.1 Vitamin A
    • 5.2.2 Vitamin B complex
    • 5.2.3 Vitamin C
    • 5.2.4 Vitamin D
    • 5.2.5 Vitamin E
    • 5.2.6 Vitamin K
  • 5.3 Mineral supplements
    • 5.3.1 Zinc supplements
    • 5.3.2 Iron supplements
    • 5.3.3 Magnesium supplements
    • 5.3.4 Other mineral supplements
  • 5.4 Herbal supplements
  • 5.5 Probiotic supplements
  • 5.6 Amino acids & proteins
  • 5.7 Omega 3 fatty acids
  • 5.8 Electrolyte supplements

Chapter 6 Market Estimates and Forecast, By Formulations, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Capsules
  • 6.3 Tablets
  • 6.4 Powder
  • 6.5 Liquid
  • 6.6 Other formulations

Chapter 7 Market Estimates and Forecast, By Source Type, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Natural
  • 7.3 Synthetic

Chapter 8 Market Estimates and Forecast, By Mode of Medication, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Prescription
  • 8.3 Over-the-counter (OTC)

Chapter 9 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 Offline retail stores
    • 9.2.1 Pharmacies & drug stores
    • 9.2.2 Hypermarkets/supermarkets
    • 9.2.3 Convenience stores
  • 9.3 Online retail stores

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 10.1 Key trends
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 France
    • 10.3.4 Spain
    • 10.3.5 Italy
    • 10.3.6 Netherlands
  • 10.4 Asia Pacific
    • 10.4.1 China
    • 10.4.2 Japan
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 South Korea
  • 10.5 Latin America
    • 10.5.1 Brazil
    • 10.5.2 Mexico
    • 10.5.3 Argentina
  • 10.6 Middle East and Africa
    • 10.6.1 South Africa
    • 10.6.2 Saudi Arabia
    • 10.6.3 UAE

Chapter 11 Company Profiles

  • 11.1 Abbott Laboratories
  • 11.2 American Health
  • 11.3 Amway
  • 11.4 Bayer
  • 11.5 Cargill
  • 11.6 Danone
  • 11.7 Herbalife Nutrition of America
  • 11.8 Himalaya Global Holdings
  • 11.9 MegaFood
  • 11.10 Metagenics
  • 11.11 Nordic Naturals
  • 11.12 NOW Foods
  • 11.13 Nestle
  • 11.14 Swisse Wellness
  • 11.15 The Nature's Bounty